Participated · Series A · Feb 2026

Handl Health provides a unified analytical and operational platform that aggregates pricing, utilization, benefit, and quality data so insurance brokers, carriers, and third-party administrators can build customizable employer health plans. Its software models provider performance, optimizes care pathways, and tracks real-world outcomes, allowing employers to move away from one-size-fits-all coverage. Over the last two years the company reports identifying $113 million in savings on nearly $1 billion of healthcare spend and enabling alternative plans that cut consumer costs on shoppable procedures by 22 percent. Handl positions itself as the infrastructure layer for the next generation of network analytics and alternative plan design, leveraging AI and newly available price-transparency datasets. With fresh capital, the team plans to expand the platform’s capabilities, deepen plan analytics, and deliver more predictable pricing and improved patient care. The $14.2 million Series A brings additional resources to accelerate product development and market penetration among the 60 percent of under-retirement-age Americans covered by employer plans.

Participated · Seed · Feb 2026

beHuman is a Miami-based, physician-led platform that combines virtual clinical care, advanced diagnostic testing, and longitudinal health data to identify cancer risk early for patients who are historically under-screened. Its agentic AI automates eligibility checks, scheduling, chart review, and follow-up, reducing clinician workload while maintaining strict clinical oversight and data-privacy safeguards. Covered by most major insurance plans, the service targets insured patients in rural and underserved communities who rarely complete recommended screenings. Early internal results indicate cancer detection rates that exceed national averages, suggesting the model’s clinical effectiveness. The company currently operates across multiple U.S. states, with a footprint in the North and Southeast. Newly secured seed funding will fuel expansion into additional states, deeper partnerships with diagnostic laboratories, further development of the AI workflow engine, and scaling of virtual care teams. The $4 million raise represents its first disclosed institutional round and strengthens its financial position for nationwide growth.

Participated · Series A · Oct 2025

Medmo operates an end-to-end orchestration platform that allows ordering providers to manage referrals for diagnostic imaging exams such as MRIs, CTs, mammograms, ultrasounds, and X-rays. The New York-based company’s technology automates the entire patient journey—from initial engagement and scheduling through prior authorization and delivery of results—helping provider groups streamline radiology workflows. Medmo’s solution is live in all 50 states and has facilitated more than one million patient journeys to date. Its AI-powered care-coordination capabilities have made it a preferred platform for providers seeking to improve efficiency and patient experience. With its expanding footprint, the company plans to build additional offerings tailored for insurance carriers. The recently secured capital will fund these developmental efforts while supporting broader operational growth.

Participated · Seed · Aug 2025

Cascala Health delivers a clinically responsible AI intelligence layer for care teams and post-acute care operators. Its AI-enabled clinical intelligence platform combines AI-powered insights, real-time communication tools, and clinical reasoning, and integrates with any web-based EMR or population health platform to streamline workflows and surface personalized interventions. The company aims to support risk-bearing organizations in delivering better care transitions and ongoing disease management. Cascala has active deployments with early customers, orchestrating care for more than 300,000 patients across thousands of post-acute transitions and empowering over 3,000 primary-care clinicians to engage in patients’ post-acute journeys. Led by CEO and co-founder Matt A. Murphy, the company was launched in mid 2024 and has raised $11.23M to date. The $8.6M seed financing will be used to accelerate product development, expand clinical intelligence capabilities, and grow its customer implementation team.

Participated · Series A · Apr 2025

Brellium provides an AI platform that helps healthcare providers streamline compliance across millions of patient visits. The platform proactively audits every patient visit, identifying compliance risks before they become problems and notifying clinical teams with clear instructions to correct charts. Clinical teams use Brellium to ensure each patient visit meets payor and clinical quality standards without the manual workload. The company serves customers including Grow Therapy, Rula, Headspace, Hopebridge, Lightfully Behavioral Health and Talkiatry. Led by CEO Zach Rosen, Brellium intends to use the new funding to grow the team and accelerate its product roadmap.